Introduction of ACI for Cartilage Repair
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-50
SponsorCentre Hospitalier Universitaire Vaudois
About this trial
This study was aimed to evaluate effectiveness and safety of autologous chondrocyte suspension for treatment of knee articular cartilage defects.
Eligibility criteria
Qualifiers
Age between 15 and 50.
Lesions classified as ICRS Grade III or IV and smaller than 15 cm2
Lesions that have failed prior therapy (conservative or surgical treatment ≥ six months)
Subjects who understand and sign the consent form for this study
Disqualifiers
Body mass index (BMI) of 35 or more
Osteoarthritis or rheumatoid arthritis
Diffuse lesion
Uncorrected mal-alignment, ligamentous instability, or meniscal tear
Trial design
Treatments tested in this trial
- autologous chondrocytes
Treatment groups
218 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov